Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract

Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract

US Patent 9980903 · Granted May 29, 2018

Estimated economic value: $6,372,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Topical naloxone compositions and methods for using the same2025
Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid2025
Crystalline 19-nor C3,3-disubstituted C21-n-pyrazolyl steroid2024
5-hydroxytryptophan gastroretentive dosage forms2023
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods 2022
Pharmaceutical formulations2022
Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid2022
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modifi2021
Methods and compositions for transdermal delivery of a non-sedative amount of de2021
Methods and compositions for treating attention deficit hyperactivity disorder, 2020
Dexmedetomidine transdermal delivery devices and methods for using the same2020
Topical sphingosine-1-phosphate receptor agonist formulations and methods of usi2020